Scotia Capital Inc. Astrazeneca PLC Transaction History

Scotia Capital Inc.

$17 Billion
Q2 2024

A detailed history of Scotia Capital Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Scotia Capital Inc. holds 373,755 shares of AZN stock, worth $28.1 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

373,755

Previous 301,594 23.93%

Holding current value

$28.1 Million

Previous $20.4 Million 42.66%

% of portfolio

0.17%

Previous 0.13%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $4.82 Million - $5.83 Million	72,161 Added 23.93%	373,755 $29.1 Million
Q1 2024 May 14, 2024	BUY	$61.03 - $69.57 $8.44 Million - $9.62 Million	138,340 Added 84.74%	301,594 $20.4 Million
Q4 2023 Feb 12, 2024	BUY	$61.89 - $69.28 $1.65 Million - $1.85 Million	26,639 Added 19.5%	163,254 $11 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $883,775 - $977,127	13,628 Added 11.08%	136,615 $9.25 Million
Q2 2023 Aug 03, 2023	BUY	$69.91 - $75.81 $775,651 - $841,111	11,095 Added 9.92%	122,987 $8.8 Million
Q1 2023 May 11, 2023	SELL	$63.15 - $71.6 $253,231 - $287,116	-4,010 Reduced 3.46%	111,892 $7.77 Million
Q4 2022 Feb 09, 2023	SELL	$54.21 - $70.44 $386,517 - $502,237	-7,130 Reduced 5.8%	115,902 $7.86 Million
Q3 2022 Nov 10, 2022	BUY	$53.02 - $135.75 $1.1 Million - $2.83 Million	20,840 Added 20.39%	123,032 $6.75 Million
Q2 2022 Aug 05, 2022	BUY	$59.26 - $71.14 $725,757 - $871,251	12,247 Added 13.62%	102,192 $6.75 Million
Q1 2022 May 09, 2022	BUY	$55.72 - $67.12 $499,919 - $602,200	8,972 Added 11.08%	89,945 $5.97 Million
Q4 2021 Feb 11, 2022	BUY	$54.02 - $63.83 $983,866 - $1.16 Million	18,213 Added 29.02%	80,973 $4.72 Million
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $2.71 Million - $2.96 Million	48,750 Added 347.97%	62,760 $3.77 Million
Q2 2021 Aug 12, 2021	SELL	$48.42 - $60.18 $200,458 - $249,145	-4,140 Reduced 22.81%	14,010 $839,000
Q1 2021 May 06, 2021	SELL	$47.16 - $54.44 $126,105 - $145,572	-2,674 Reduced 12.84%	18,150 $902,000
Q4 2020 Feb 11, 2021	BUY	$48.52 - $58.02 $93,983 - $112,384	1,937 Added 10.26%	20,824 $1.04 Million
Q3 2020 Nov 12, 2020	BUY	$53.07 - $61.1 $1 Million - $1.15 Million	18,887 New	18,887 $1.04 Million
Q2 2020 Aug 11, 2020	SELL	$43.1 - $55.31 $485,392 - $622,901	-11,262 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$37.79 - $51.33 $41,380 - $56,206	1,095 Added 10.77%	11,262 $503,000
Q4 2019 Feb 13, 2020	BUY	$42.46 - $50.46 $8,492 - $10,092	200 Added 2.01%	10,167 $507,000
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $5,416 - $6,138	-135 Reduced 1.34%	9,967 $444,000
Q2 2019 Aug 13, 2019	BUY	$37.28 - $41.68 $5,032 - $5,626	135 Added 1.35%	10,102 $417,000
Q1 2019 May 15, 2019	BUY	$35.49 - $43.02 $151,222 - $183,308	4,261 Added 74.68%	9,967 $403,000
Q4 2018 Feb 11, 2019	SELL	$36.86 - $41.49 $28,750 - $32,362	-780 Reduced 12.03%	5,706 $217,000
Q3 2018 Nov 14, 2018	BUY	$34.76 - $39.72 $23,289 - $26,612	670 Added 11.52%	6,486 $257,000
Q1 2018 May 15, 2018	BUY	$32.97 - $36.63 $191,753 - $213,040	5,816 New	5,816 $203,000

Others Institutions Holding AZN

# of Institutions

1,343

Shares Held

492M

Call Options Held

4.99M

Put Options Held

3.19M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $233B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scotia Capital Inc. with notifications on news.

Account

Scotia Capital Inc. Astrazeneca PLC Transaction History